S. Ward

The conformational switch in 7-transmembrane receptors: the muscarinic receptor paradigm.

E. Hulme, Z. L. Lu, S. Ward, 1999, European journal of pharmacology.

Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy*

J. Wess, F. Hamdan, S. Ward, 2002, The Journal of Biological Chemistry.

Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers.

C. Earnshaw, S. Ward, Andreá Fiumana, 2007, Bioorganic & medicinal chemistry letters.

Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor.

J. Wess, F. Hamdan, S. Ward, 2006, Biochemistry.

Alanine-scanning mutagenesis of transmembrane domain 6 of the M(1) muscarinic acetylcholine receptor suggests that Tyr381 plays key roles in receptor function.

E. Hulme, S. Ward, C. Curtis, 1999, Molecular pharmacology.

Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.

J. Wess, F. Hamdan, S. Ward, 2002, Biochemistry.

BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors

A. Goetz, S. Ward, T. Rimele, 1995 .

BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors.

A. Goetz, S. Ward, T. Rimele, 1995, European journal of pharmacology.